2799 related articles for article (PubMed ID: 15286445)
1. Evaluation of recombinant and native timothy pollen (rPhl p 1, 2, 5, 6, 7, 11, 12 and nPhl p 4)- specific IgG4 antibodies induced by subcutaneous immunotherapy with timothy pollen extract in allergic patients.
Rossi RE; Monasterolo G
Int Arch Allergy Immunol; 2004 Sep; 135(1):44-53. PubMed ID: 15286445
[TBL] [Abstract][Full Text] [Related]
2. Possible relationship between systemic side effects and sensitization to rPar j 2 in allergic patients submitted to an ultra-rush (20 min) sublingual immunotherapy and selected by component resolved diagnosis.
Rossi RE; Monasterolo G; Coco G; Operti D
Int Arch Allergy Immunol; 2005 Oct; 138(2):105-10. PubMed ID: 16174987
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of serum IgG4 antibodies specific to grass pollen allergen components in the follow up of allergic patients undergoing subcutaneous and sublingual immunotherapy.
Rossi RE; Monasterolo G; Coco G; Silvestro L; Operti D
Vaccine; 2007 Jan; 25(5):957-64. PubMed ID: 17045368
[TBL] [Abstract][Full Text] [Related]
4. IgE profiles of Bermuda grass pollen sensitised patients evaluated by Phleum pratense allergens Phl P 1, 2, 4, 5, 6 , 7, 11, 12.
Rossi RE; Monasterolo G; Prina P; Coco G; Operti D; Rossi L
Allergol Int; 2008 Jun; 57(2):157-64. PubMed ID: 18349590
[TBL] [Abstract][Full Text] [Related]
5. Molecular profiles of IgE to Phleum pratense in children with grass pollen allergy: implications for specific immunotherapy.
Tripodi S; Frediani T; Lucarelli S; Macrì F; Pingitore G; Di Rienzo Businco A; Dondi A; Pansa P; Ragusa G; Asero R; Faggian D; Plebani M; Matricardi PM
J Allergy Clin Immunol; 2012 Mar; 129(3):834-839.e8. PubMed ID: 22206774
[TBL] [Abstract][Full Text] [Related]
6. Pretreatment IgE sensitization patterns determine the molecular profile of the IgG4 response during updosing of subcutaneous immunotherapy with timothy grass pollen extract.
Schmid JM; Würtzen PA; Dahl R; Hoffmann HJ
J Allergy Clin Immunol; 2016 Feb; 137(2):562-70. PubMed ID: 26141262
[TBL] [Abstract][Full Text] [Related]
7. Specific subcutaneous immunotherapy with recombinant grass pollen allergens: first randomized dose-ranging safety study.
Klimek L; Schendzielorz P; Pinol R; Pfaar O
Clin Exp Allergy; 2012 Jun; 42(6):936-45. PubMed ID: 22909165
[TBL] [Abstract][Full Text] [Related]
8. Skin test with a timothy grass (Phleum pratense) pollen extract vs. IgE to a timothy extract vs. IgE to rPhl p 1, rPhl p 2, nPhl p 4, rPhl p 5, rPhl p 6, rPhl p 7, rPhl p 11, and rPhl p 12: epidemiological and diagnostic data.
Mari A
Clin Exp Allergy; 2003 Jan; 33(1):43-51. PubMed ID: 12534548
[TBL] [Abstract][Full Text] [Related]
9. Immunotherapy with a Phleum pratense allergen extract induces an immune response to a grass-mix allergen extract.
Martínez-Cócera C; Sastre J; Cimarra M; Quirce S; Fernández-Rivas M; Enríquez-Matas A; Rodríguez-Alvarez M; Martín S
J Investig Allergol Clin Immunol; 2010; 20(1):13-9. PubMed ID: 20232769
[TBL] [Abstract][Full Text] [Related]
10. Allergens. Heterogeneity of molecular sensitization profiles in grass pollen allergy--implications for immunotherapy?
Darsow U; Brockow K; Pfab F; Jakob T; Petersson CJ; Borres MP; Ring J; Behrendt H; Huss-Marp J
Clin Exp Allergy; 2014; 44(5):778-86. PubMed ID: 24598010
[TBL] [Abstract][Full Text] [Related]
11. Phleum pratense alone is sufficient for allergen-specific immunotherapy against allergy to Pooideae grass pollens.
Hejl C; Wurtzen PA; Kleine-Tebbe J; Johansen N; Broge L; Ipsen H
Clin Exp Allergy; 2009 May; 39(5):752-9. PubMed ID: 19222498
[TBL] [Abstract][Full Text] [Related]
12. Heterogeneity of commercial timothy grass pollen extracts.
Focke M; Marth K; Flicker S; Valenta R
Clin Exp Allergy; 2008 Aug; 38(8):1400-8. PubMed ID: 18564332
[TBL] [Abstract][Full Text] [Related]
13. Recombinant allergen-based monitoring of antibody responses during injection grass pollen immunotherapy and after 5 years of discontinuation.
Gadermaier E; Staikuniene J; Scheiblhofer S; Thalhamer J; Kundi M; Westritschnig K; Swoboda I; Flicker S; Valenta R
Allergy; 2011 Sep; 66(9):1174-82. PubMed ID: 21480924
[TBL] [Abstract][Full Text] [Related]
14. Purification, structural and immunological characterization of a timothy grass (Phleum pratense) pollen allergen, Phl p 4, with cross-reactive potential.
Stumvoll S; Lidholm J; Thunberg R; DeWitt AM; Eibensteiner P; Swoboda I; Bugajska-Schretter A; Spitzauer S; Vangelista L; Kazemi-Shirazi L; Sperr WR; Valent P; Kraft D; Valenta R
Biol Chem; 2002 Sep; 383(9):1383-96. PubMed ID: 12437131
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of IgE antibodies to recombinant pollen allergens (Phl p 1, Phl p 2, and Phl p 5) in a random sample of patients with specific IgE to Phleum pratense.
Rossi RE; Monasterolo G; Operti D; Operti R; Berlen R
Allergy; 2000 Feb; 55(2):181-4. PubMed ID: 10726734
[TBL] [Abstract][Full Text] [Related]
16. Nasal allergen-neutralizing IgG
Shamji MH; Kappen J; Abubakar-Waziri H; Zhang J; Steveling E; Watchman S; Kouser L; Eifan A; Switzer A; Varricchi G; Marone G; Couto-Francisco NC; Calderon M; Durham SR
J Allergy Clin Immunol; 2019 Mar; 143(3):1067-1076. PubMed ID: 30445057
[TBL] [Abstract][Full Text] [Related]
17. Grass pollen immunotherapy as an effective therapy for childhood seasonal allergic asthma.
Roberts G; Hurley C; Turcanu V; Lack G
J Allergy Clin Immunol; 2006 Feb; 117(2):263-8. PubMed ID: 16461125
[TBL] [Abstract][Full Text] [Related]
18. Spatial clustering of the IgE epitopes on the major timothy grass pollen allergen Phl p 1: importance for allergenic activity.
Flicker S; Steinberger P; Ball T; Krauth MT; Verdino P; Valent P; Almo S; Valenta R
J Allergy Clin Immunol; 2006 Jun; 117(6):1336-43. PubMed ID: 16750995
[TBL] [Abstract][Full Text] [Related]
19. IgE reactivity pattern to timothy and birch pollen allergens in Finnish and Russian Karelia.
Movérare R; Petays T; Vartiainen E; Haahtela T
Int Arch Allergy Immunol; 2005 Jan; 136(1):33-8. PubMed ID: 15591811
[TBL] [Abstract][Full Text] [Related]
20. Immunologic effect and tolerability of intra-seasonal subcutaneous immunotherapy with an 8-day up-dosing schedule to 10,000 standardized quality-units: a double-blind, randomized, placebo-controlled trial.
Pfaar O; Wolf H; Klimek L; Schnitker J; Wüstenberg E
Clin Ther; 2012 Oct; 34(10):2072-81. PubMed ID: 23063373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
